Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
Saved in:
| Title: | Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. |
|---|---|
| Authors: | Sattler A; Department for General and Visceral Surgery and., Schrezenmeier E; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Weber UA; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Potekhin A; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.; MVZ Diaverum Neubrandenburg, Neubrandenburg, Germany., Bachmann F; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Straub-Hohenbleicher H; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Budde K; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Storz E; Department for General and Visceral Surgery and., Proß V; Department for General and Visceral Surgery and., Bergmann Y; Department for General and Visceral Surgery and., Thole LM; Department for General and Visceral Surgery and., Tizian C; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Hölsken O; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.; Heidelberg Bioscience International Graduate School, Heidelberg University, Heidelberg, Germany., Diefenbach A; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Schrezenmeier H; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany., Jahrsdörfer B; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany., Zemojtel T; Genomics Core Facility., Jechow K; Center for Digital Health, and., Conrad C; Center for Digital Health, and., Lukassen S; Center for Digital Health, and., Stauch D; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Lachmann N; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Choi M; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Halleck F; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Kotsch K; Department for General and Visceral Surgery and. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2021 Jul 15; Vol. 131 (14). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34101623 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sattler+A%22">Sattler A</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Schrezenmeier+E%22">Schrezenmeier E</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Weber+UA%22">Weber UA</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Potekhin+A%22">Potekhin A</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.; MVZ Diaverum Neubrandenburg, Neubrandenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bachmann+F%22">Bachmann F</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Straub-Hohenbleicher+H%22">Straub-Hohenbleicher H</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Budde+K%22">Budde K</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Storz+E%22">Storz E</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Proß+V%22">Proß V</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Bergmann+Y%22">Bergmann Y</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Thole+LM%22">Thole LM</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Tizian+C%22">Tizian C</searchLink>; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hölsken+O%22">Hölsken O</searchLink>; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.; Heidelberg Bioscience International Graduate School, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Diefenbach+A%22">Diefenbach A</searchLink>; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schrezenmeier+H%22">Schrezenmeier H</searchLink>; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Jahrsdörfer+B%22">Jahrsdörfer B</searchLink>; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Zemojtel+T%22">Zemojtel T</searchLink>; Genomics Core Facility.<br /><searchLink fieldCode="AU" term="%22Jechow+K%22">Jechow K</searchLink>; Center for Digital Health, and.<br /><searchLink fieldCode="AU" term="%22Conrad+C%22">Conrad C</searchLink>; Center for Digital Health, and.<br /><searchLink fieldCode="AU" term="%22Lukassen+S%22">Lukassen S</searchLink>; Center for Digital Health, and.<br /><searchLink fieldCode="AU" term="%22Stauch+D%22">Stauch D</searchLink>; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lachmann+N%22">Lachmann N</searchLink>; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Choi+M%22">Choi M</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Halleck+F%22">Halleck F</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kotsch+K%22">Kotsch K</searchLink>; Department for General and Visceral Surgery and. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2021 Jul 15; Vol. 131 (14). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34101623 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI150175 Languages: – Code: eng Text: English Titles: – TitleFull: Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sattler A – PersonEntity: Name: NameFull: Schrezenmeier E – PersonEntity: Name: NameFull: Weber UA – PersonEntity: Name: NameFull: Potekhin A – PersonEntity: Name: NameFull: Bachmann F – PersonEntity: Name: NameFull: Straub-Hohenbleicher H – PersonEntity: Name: NameFull: Budde K – PersonEntity: Name: NameFull: Storz E – PersonEntity: Name: NameFull: Proß V – PersonEntity: Name: NameFull: Bergmann Y – PersonEntity: Name: NameFull: Thole LM – PersonEntity: Name: NameFull: Tizian C – PersonEntity: Name: NameFull: Hölsken O – PersonEntity: Name: NameFull: Diefenbach A – PersonEntity: Name: NameFull: Schrezenmeier H – PersonEntity: Name: NameFull: Jahrsdörfer B – PersonEntity: Name: NameFull: Zemojtel T – PersonEntity: Name: NameFull: Jechow K – PersonEntity: Name: NameFull: Conrad C – PersonEntity: Name: NameFull: Lukassen S – PersonEntity: Name: NameFull: Stauch D – PersonEntity: Name: NameFull: Lachmann N – PersonEntity: Name: NameFull: Choi M – PersonEntity: Name: NameFull: Halleck F – PersonEntity: Name: NameFull: Kotsch K IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 07 Text: 2021 Jul 15 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 131 – Type: issue Value: 14 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |